SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Rubicon Research lists with 28% premium on the BSE

16 Oct 2025 Evaluate

Rubicon Research has debuted at Rs 620.10 on the BSE, up by 135.10 points or 27.86% from its issue price of Rs 485.00.

The scrip is currently trading at Rs. 602.15, up by 117.15 points or 24.15% from its issue price.

It has touched a high and low of Rs. 620.10 and Rs. 590.00 respectively. So far 11.90 lakh shares were traded on the counter.

The offering, which was open for subscription between October 09, 2025 and October 13, 2025 was subscribed 109.35 times. The issue price was fixed at Rs 485.00 per share i.e. at upper end of price band of Rs 461-485 apiece.

Rubicon Research is a pharmaceutical formulations company, driven by innovation through focused research and development, with an increasing portfolio of speciality products and drug-device combination products targeting regulated markets and in particular the United States. 

Rubicon Research Share Price

942.30 14.55 (1.57%)
24-Apr-2026 14:56 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×